Welcome. MP Healthcare Venture Management (MPH)
is a Boston-based lifesciences venture capital firm passionate about connecting ideas, technologies, and business processes to create tomorrow’s healthcare innovations. Find out how connecting with MPH can get your ideas to market faster and bring value to your vision. More

News and Events

10 November 2015

miRagen Therapeutics Secures $41 million Series C Financing to Advance Two MicroRNA Programs into Clinical Trials.More

7 July 2015

Thrasos Completes Enrollment of Phase 2 THR -184 Clinical Study for Acute Kidney Injury .More

31 March 2015

Thrasos Secures $21 Million to Complete Phase 2 Study of THR-184 in the Prevention of Acute Kidney Injury and Expand the Company's Renal Portfolio.More

4 November 2014

F-star Announces the Formation of Second Asset-Centric Vehicle, F-star Beta Ltd.More

28 October 2014

Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy.More

16 September 2014

Thrasos Announces Successful Formal Interim Analysis and Clinical Update.More



Featured Portfolio